Treatment of metabolic alkalosis during continuous renal replacement therapy with regional citrate anticoagulation

International Journal of Artificial Organs

Volumn 31, Issue 4, 2008, Pages 363-366

  Kindgen Milles, D ^a   Amman, J ^a   Kleinekofort, Wolfgang ^b   Morgera, S ^c  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b RHEINMAIN UNIVERSITY OF APPLIED SCIENCES   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Anticoagulation; Citrate; Hemodialysis; Monitoring

Indexed keywords

HEMODIALYZERS; METABOLISM;

AND FILTERS; ANTI-COAGULATION; BLEEDINGS; CASE REPORTS; CITRATE; FILTER LIFE; HAEMODIALYSIS; LIFE-TIMES; RENAL REPLACEMENT THERAPIES; SYSTEMIC CIRCULATION;

DIALYSIS;

ANTICOAGULANT AGENT; BICARBONATE; CALCIUM; CITRIC ACID;

ACID BASE BALANCE; ACUTE KIDNEY FAILURE; AGED; ALGORITHM; ANTICOAGULATION; ARTERIAL GAS; ARTICLE; ARTIFICIAL VENTILATION; BICARBONATE BLOOD LEVEL; BLEEDING; BLOOD FLOW; CARDIOGENIC SHOCK; CASE REPORT; CONTINUOUS INFUSION; CONTINUOUS RENAL REPLACEMENT THERAPY; CORONARY ARTERY BYPASS GRAFT; DEVICE THERAPY; DIALYSATE LEVEL; HEMODIALYSIS; HUMAN; MALE; METABOLIC ALKALOSIS; PH; RISK FACTOR; SYSTEMIC CIRCULATION; ULTRAFILTRATION;

EID: 45949094361     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880803100414     Document Type: Article

References (9)

1. van de Wetering J, Westendorp RG, van der Hoeven JG, Stolk B, Feuth JD, Chang PC. Heparin Use in continuous renal replacement procedures: the struggle between filter coagulation and patient hemorrhage. J Am Soc Nephrol 1996; 7: 145-50.
2. Mehta RL, McDonald BR, Aguilar MM, Ward DM. Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 1990; 38; 976-81.
3. Morgera S, Haase M, Rückert M, Krieg H, Kastrup M, Krausch D, Vargas-Hein O, Zuckermann-Becker H, Peters H, Pohlmeier R, Neumayer HH. Regional citrate anticoagulation in continuous hemodialysis - acid-base and electrolyte balance at an increased dose of dialysis. Nephron Clin Pract 2005; 101; c211-9.
4. Swartz R, Pasko D, O'Toole J, Starmann B. Improving the delivery of continuous renal replacement therapy using regional citrate anticoagulation. Clin Nephrol 2004; 61; 134-43.
5. Monchi M, Berghmans D, Ledoux D, Canivet JL, Dubois B, Damas P. Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study. Intensive Care Med 2004; 30; 260-5.
6. Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G. Effects of different doses in continuous venovenous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 2000; 356: 26-30.
7. Saudan P, Niederberger M, De Seigneux S, Romand J, Pugin J, Perneger T, Martin PY. Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure. Kidney Int 2006; 70; 1312-17.
8. Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 2000; 356: 26-30.
9. Saudan P, Niederberger M, De Seigneux S, Romand J, Pugin J, Perneger T, Martin PY. Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure. Kidney Int 2006; 70: 1312-7.